TAUNS LaboratoriesInc Future Growth
Future criteria checks 3/6
TAUNS LaboratoriesInc is forecast to grow earnings and revenue by 3.6% and 5.5% per annum respectively. EPS is expected to grow by 3.6% per annum. Return on equity is forecast to be 29.3% in 3 years.
Key information
3.6%
Earnings growth rate
3.6%
EPS growth rate
| Medical Equipment earnings growth | 12.8% |
| Revenue growth rate | 5.5% |
| Future return on equity | 29.3% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 21,377 | 6,121 | 6,800 | 7,940 | 3 |
| 6/30/2026 | 20,233 | 6,833 | 3,000 | 7,481 | 3 |
| 6/30/2025 | 20,000 | 6,350 | 3,200 | 6,687 | 1 |
| 6/30/2024 | 18,435 | 5,774 | 5,974 | 9,935 | N/A |
| 6/30/2023 | 15,673 | 3,035 | -4,323 | -3,158 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 197A's forecast earnings growth (3.6% per year) is above the savings rate (0.3%).
Earnings vs Market: 197A's earnings (3.6% per year) are forecast to grow slower than the JP market (7.9% per year).
High Growth Earnings: 197A's earnings are forecast to grow, but not significantly.
Revenue vs Market: 197A's revenue (5.5% per year) is forecast to grow faster than the JP market (4.1% per year).
High Growth Revenue: 197A's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 197A's Return on Equity is forecast to be high in 3 years time (29.3%)